Related Experiment Videos

[Possible applications of cytokines in clinical oncology]

M Z Wojtukiewicz¹, Z Sawicki

¹Zakład Onkologii Akademii Medycznej w Białymstoku.

Polskie Archiwum Medycyny Wewnetrznej

|November 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

European journal of cancer (Oxford, England : 1990)·2018

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.

Neoplasma·2006

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.

Bone marrow transplantation·2004

Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

Roczniki Akademii Medycznej w Bialymstoku (1995)·2004

A rare localization of Hodgkin's disease in the breast--a case report.

Roczniki Akademii Medycznej w Bialymstoku (1995)·2002

See all related articles